METASTATIC SARCOMA

Clinical trials for METASTATIC SARCOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC SARCOMA trials appear

Sign up with your email to follow new studies for METASTATIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1 Terminated 1

Pazopanib dose hunt in frail seniors halted early

Disease control Terminated

This phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…

Matched conditions: METASTATIC SARCOMA

Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

METASTATIC SARCOMA

Get alerted when new METASTATIC SARCOMA trials appear

Pazopanib dose hunt in frail seniors halted early